2012-22821. Agency Information Collection Activities; Proposed Collection; Unique Device Identification System; Extension of Comment Period  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notification; extension of comment period.

    SUMMARY:

    The Food and Drug Administration (FDA) is extending the comment period pertaining to information collection issues under the Paperwork Reduction Act of 1995 (the PRA) associated with the proposed rule, Unique Device Identification System, that appeared in the Federal Register of July 10, 2012 (77 FR 40736). The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

    DATES:

    Submit either electronic or written comments on the proposed collection of information by October 25, 2012.

    ADDRESSES:

    Submit electronic comments on the collection of information to the Office of Regulatory Affairs, Office of Management and Budget (OMB) at FAX: 202-395-7285, or email comments to OIRA_submissions@omb.eop.gov. Please mark your comment to the FDA desk officer and reference this rule.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jay Crowley, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-5995, email: cdrhudi@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    In the Federal Register of July 10, 2012 (77 FR 40736), FDA published a notice of proposed rulemaking with a 60-day comment period concerning the proposed information collection. Comments on the proposed rulemaking will inform FDA's rulemaking to establish regulations for Unique Device Identification System.

    The Agency has received requests for a 45-day extension of the comment period for the information collection. Each request conveyed concern that the current 60-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the information collection.

    FDA has considered the requests and is extending the comment period for the information collection for 45 days, until October 25, 2012. The Agency believes that a 45-day extension allows adequate time for interested persons to submit comments without significantly delaying rulemaking on these important issues.

    Start Signature

    Dated: September 12, 2012.

    Leslie Kux,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2012-22821 Filed 9-14-12; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Published:
09/17/2012
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notification; extension of comment period.
Document Number:
2012-22821
Dates:
Submit either electronic or written comments on the proposed collection of information by October 25, 2012.
Pages:
57055-57055 (1 pages)
Docket Numbers:
Docket No. FDA-2011-N-0090
RINs:
0910-AG31: Unique Device Identification
RIN Links:
https://www.federalregister.gov/regulations/0910-AG31/unique-device-identification
PDF File:
2012-22821.pdf
Supporting Documents:
» Alphatec Spine - Supplement
» duplicate submission
» duplicate submission
» see docket 2011-n-0719
CFR: (10)
21 CFR 16
21 CFR 801
21 CFR 803
21 CFR 806
21 CFR 810
More ...